Cernostics created a medical advisory board with experts on gastroesophageal reflux disease, Barrett's esophagus and esophageal cancer to assist the company going forward.
What you should know:
1. The board includes:
2. Cernostics creates tissue-based diagnostic tests that aim to improve patient outcomes and lower care costs.
"Timing is right to bring together this world-class group of medical advisors to provide strategic insights into our evidence development and market access strategies," said Cernostics CEO Mike Hoerres.
More articles on gastroenterology:
3 things to know about outpatient cervical disc replacement
10 things to know about spine surgery for ASCs in 2019
Outpatient revision minimally invasive lumbar decompression: 4 notes on ASC vs. HOPD
© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.